Essais liés4clinical trials
VilleWest Hillslocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT06848075

Ouvrir le site du centre

Essais cliniques associés

4
MoléculeIndication / populationPhaseNCTTitreStatut
Elismetrep (K-304) 2 mg Migraine Phase 2 NCT06848075 A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine COMPLETED
BI 3000202 Lupus Phase 2 NCT07409181 A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE) RECRUITING
Elismetrep Migraine Phase 3 NCT07645924 A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine RECRUITING
Elismetrep Migraine Phase 3 NCT07674654 A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine RECRUITING